Understanding antibodies to avoid pandemics

Structural biologist Pamela Björkman shared insights into pandemic viruses as part of the Department of Biology’s IAP seminar series.

Saima Sidik | Department of Biology • mit
Jan. 19, 2021 ~5 min

Neural vulnerability in Huntington’s disease tied to release of mitochondrial RNA

Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.

David Orenstein | Picower Institute for Learning and Memory • mit
July 21, 2020 ~7 min

Research highlights immune molecule’s complex role in Huntington’s disease

Knocking out the immune cytokine IL-6 exacerbates symptoms in HD model mice, affects neural connection genes.

David Orenstein | Picower Institute for Learning and Memory • mit
June 8, 2020 ~4 min

Counting your antigens

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Bendta Schroeder | Koch Institute • mit
June 2, 2020 ~9 min

Technique identifies T cells primed for certain allergies or infections

Researchers develop a method to isolate and sequence the RNA of T cells that react to a specific target.

Anne Trafton | MIT News Office • mit
Nov. 19, 2019 ~8 min

Soft robotics breakthrough manages immune response for implanted devices

Discovery could enable longer-lasting and better-functioning devices — including pacemakers, breast implants, biosensors, and drug delivery devices.

Institute for Medical Engineering and Science • mit
Sept. 4, 2019 ~5 min

Unmasking mutant cancer cells

A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.

Bendta Schroeder | Koch Institute • mit
July 17, 2019 ~5 min

New vaccine strategy boosts T-cell therapy

Super-charging a treatment for leukemia also makes it effective on solid tumors.

Anne Trafton | MIT News Office • mit
July 11, 2019 ~7 min

A new approach to targeting tumors and tracking their spread

Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.

Helen Knight | MIT News correspondent • mit
May 6, 2019 ~7 min

“Inactive” ingredients may not be, study finds

Most pills contain compounds with potential to cause allergic reactions or discomfort in some patients.

Anne Trafton | MIT News Office • mit
March 13, 2019 ~8 min

/

2